Tuesday, October 16, 2018
Tags Opdivo

Tag: Opdivo

Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

Roche’s Tecentriq, Trailing Rival Drugs, Lifts Lung Cancer Survival

By John Miller ZURICH (Reuters)  A drug cocktail with Roche's Tecentriq added two months to small-cell lung cancer patients' lives, according to a study, aiding the...
Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...
Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage

Mixed Results for Bristol/Nektar Combination in Cancer Trial

Chicago (Reuters) Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led...
Bottles of medications line the shelves at a pharmacy in Portsmouth

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...
Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland

Roche, Chasing Merck, Notches Another Lung Cancer Win

By John Miller ZURICH (Reuters) Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker...
US-MERCK-CO-STUDY

Merck’s Keytruda Helps Lung Cancer Patients Live Longer in Trial

By Tamara Mathias (Reuters) Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its...
banner